Skip Navigation



Carcinogenesis Advance Access published online on January 19, 2008

Carcinogenesis, doi:10.1093/carcin/bgn001
This Article
Right arrow Advance Access manuscript (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
29/3/666    most recent
bgn001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Oyama, T.
Right arrow Articles by Mori, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oyama, T.
Right arrow Articles by Mori, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Further upregulation of β-catenin/Tcf transcription is involved in the development of macroscopic tumors in the colon of Apc Min/+ mice

Takeru Oyama1, Yasuhiro Yamada1,*, Kazuya Hata1, Hiroyuki Tomita1, Akihiro Hirata2, HongQiang Sheng1, Akira Hara1, Hitomi Aoki3, Takahiro Kunisada3, Satoshi Yamashita4 and Hideki Mori1

1 Department of Tumor Pathology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan
2 Division of Animal Experiment, Life Science Research Center, Gifu University, Yanagido 1-1, Gifu, 501-1193, Japan
3 Department of Tissue and Organ Development, Regeneration and Advanced Medical Science, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan
4 Carcinogenesis Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan

* To whom corresponding should be addressed: y-yamada{at}gifu-u.ac.jp

Apc Min/+ mouse, a mouse model for human familial adenomatosis polyposis (FAP), contains a truncating mutation in the Apc gene and spontaneously develops intestinal tumors. Our previous study revealed two distinct stages of tumorigenesis in the colon of Apc Min/+ mouse; microadenomas and macroscopic tumors. Microadenomas already have lost their remaining allele of the Apc and all microadenomas show accumulation of β-catenin, indicating that activation of the canonical Wnt pathway is an initiating event in the tumorigenesis. This study shows that expression of nuclear β-catenin in macroscopic tumors is further upregulated in comparison with that in microadenomas. Furthermore, transcriptional activity of β-catenin/T-cell factor (Tcf) signaling, assessed using β-catenin/Tcf reporter transgenic mice is higher in the macroscopic tumors than that in microadenomas. In addition, the expression level of Dickkopf-1 (Dkk1), which is known to be a negative modifier of the canonical Wnt pathway, was reduced only in colon tumors. These results suggest that activation of β-catenin/Tcf transcription plays a role, not only in the initiation stage, but also in the promotion stage of colon carcinogenesis in Apc Min/+ mice.

Received July 11, 2007; revised December 16, 2007; accepted December 28, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
X. Liu, L. Wang, S. Zhang, J. Lin, S. Zhang, M. A. Feitelson, H. Gao, and M. Zhu
Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses
Carcinogenesis, June 1, 2008; 29(6): 1207 - 1214.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.